{"entity":{"type":"insider","cik":"0001705287","url":"/insider/0001705287","json_url":"/insider/0001705287.json","name":"FLESHER GREGORY J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":3,"first":"2017-05-11","last":"2021-08-26","span_basis":"filed_date"},"name_variants":[{"name":"FLESHER GREGORY J.","source":"filing","n_filings":3,"first_seen":"2017-05-11","last_seen":"2021-08-26"}],"transactions":[{"id":5252651,"accession":"0001209191-21-053522","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-053522","line_url":"/filing/0001209191-21-053522#line-1","is_derivative":false,"issuer_cik":"0001637715","issuer_name":"Reneo Pharmaceuticals, Inc.","issuer_ticker":"RPHM","issuer_name_source":null,"issuer_url":"/issuer/0001637715","owner_cik":"0001705287","owner_name":"FLESHER GREGORY J.","owner_url":"/insider/0001705287","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":64000.0,"total_display":"64,000.00","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-25","filed_date":"2021-08-26","scope":"insider"},{"id":7937982,"accession":"0001562180-19-003051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-19-003051","line_url":"/filing/0001562180-19-003051#line-2","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Novus Therapeutics, Inc.","issuer_ticker":"NVUS","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001705287","owner_name":"FLESHER GREGORY J.","owner_url":"/insider/0001705287","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2937.0,"shares_display":"2,937","price_per_share":1.9114,"price_display":"1.91","price_state":"stated","total_value":5613.7818,"total_display":"5,613.78","shares_owned_after":156918.0,"shares_owned_after_display":"156,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-21","filed_date":"2019-05-22","scope":"insider"},{"id":7937978,"accession":"0001562180-19-003051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-003051","line_url":"/filing/0001562180-19-003051#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Novus Therapeutics, Inc.","issuer_ticker":"NVUS","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001705287","owner_name":"FLESHER GREGORY J.","owner_url":"/insider/0001705287","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11701.0,"shares_display":"11,701","price_per_share":1.9616,"price_display":"1.96","price_state":"stated","total_value":22952.6816,"total_display":"22,952.68","shares_owned_after":159855.0,"shares_owned_after_display":"159,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-22","scope":"insider"},{"id":4690912,"accession":"0000899243-17-012936","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-012936","line_url":"/filing/0000899243-17-012936#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Novus Therapeutics, Inc.","issuer_ticker":"NVUS","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001705287","owner_name":"FLESHER GREGORY J.","owner_url":"/insider/0001705287","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58959.0,"shares_display":"58,959","price_per_share":9.99,"price_display":"9.99","price_state":"stated","total_value":589000.41,"total_display":"589,000.41","shares_owned_after":115856.0,"shares_owned_after_display":"115,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-10","filed_date":"2017-05-11","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001637715","name":"Reneo Pharmaceuticals, Inc.","url":"/issuer/0001637715","role":"Director, Officer (President and CEO)","n_filings":1,"first_seen":"2021-08-26","last_seen":"2021-08-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001404281","name":"Novus Therapeutics, Inc.","url":"/issuer/0001404281","role":"Director, Officer (Chief Executive Officer)","n_filings":2,"first_seen":"2017-05-11","last_seen":"2019-05-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001705287","retrieved_at":"2026-08-22T04:33:06+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}